THERAPEUTICS
Review: little evidence exists on the benefits and harms of screening for and treating gestational diabetes
| The first 150 words of the full text of this article appear below. |
T A Hillier
Dr T A Hillier, Kaiser Permanente Northwest, Portland, OR, USA
QUESTION
What are the benefits and harms of screening for and treating gestational diabetes mellitus (GDM)?
REVIEW SCOPE
The review sought to answer the following questions: Are screening tests for GDM accurate? Does screening and treatment for GDM reduce perinatal morbidity and mortality in the mother and infant? What are the harms associated with these interventions? Neonatal outcomes were mortality and morbidity; maternal outcomes were mortality, pre-eclampsia, and pregnancy-induced hypertension.
REVIEW METHODS
Medline and 5 other databases (2000 to Nov 2007) and references were searched for studies that used a 1-step or 2-step screening method and recognised diagnostic criteria for GDM. Experts were consulted. 7 randomised controlled trials (RCTs) (n = 2469), 4 prospective cohort studies (n = 793), and 1 cross-sectional study (n = 118) met the selection criteria.
MAIN RESULTS
No appropriate study was found on benefits or accuracy of screening for
Temple Sowerby Medical Practice, Penrith, UK
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
